SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-03 12:32:26 ET
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call March 3, 2026 8:00 AM EST
Company Participants
Kellen Sanger - Head of Strategy and Investor Relations
Jurgi Camblong - Co-Founder, CEO & Director
Ross Muken - President
George Cardoza - Executive VP & CFO
...
Read the full article on Seeking Alpha
For further details see:
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript
SOPHiA GENETICS SA
NASDAQ: SOPH
SOPH Trading
2.23% G/L:
$4.355 Last:
37,828 Volume:
$4.40 Open:
SOPH Latest News
SOPH Stock Data
$320,789,141
55,476,472
N/A
27
N/A
Healthcare Providers & Services
Healthcare
CH
Rolle
